Male breast cancer: Immunohistochemical subtypes and clinical outcome characterization

Oncology (Switzerland)

Volumn 83, Issue 4, 2012, Pages 228-233

  Snchez Muoz, Alfonso ^a   Romn Jobacho, Alicia ^b   Prez Villa, Lidia ^a   Snchez Rovira, Pedro ^b   Miramn, Jos ^c   Prez, Diego ^d   Sez, Maria Isabel ^a   De Luque, Vanesa ^a   Medina, Laura ^a   Ramrez Tortosa, Csar Luis ^b   Vicioso, Luis ^a   Medina, Jos Antonio ^b   Ribelles, Nuria ^a   Alba, Emilio ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^b Department of Radiation Oncology ^*  (Spain)

^c Medical Oncology Service   (Spain)

^d HOSPITAL COSTA DEL SOL   (Spain)

Author keywords

Breast cancer subtypes; Immunohistochemistry; Male breast cancer

Indexed keywords

CYTOKERATIN 5; CYTOKERATIN 6; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER CLASSIFICATION; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUMINAL A BREAST CANCER; LUMINAL B BREAST CANCER; MALE; MALE BREAST CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGESTERONE RECEPTOR POSITIVE BREAST CANCER; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS, MALE; CARCINOMA, BASAL CELL; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84865059574     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000341537     Document Type: Article

References (25)

1. Korde LA, Zujewski JA, Kamin L, et al: Mul-tidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol 2010; 28:2114-2122.
2. Giordano SH: A review of the diagnosis and management of male breast cancer. Oncologist 2005; 10: 471-479. (Pubitemid 41266328)
3. Perou CM, Sorlie T, Eisen MD, et al: Molecular portraits of human breast tumors. Nature 2000; 406:747-752.
4. Sorlie T, Perou CM, Tibshirani R, et al: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001; 98:10869-10874. (Pubitemid 32878711)
5. Sorlie T, Tibshirani R, Parker J, et al: Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003; 100:8418-8423. (Pubitemid 36842560)
6. Rouzier R, Perou CM, Symmans WF, et al: Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 2005; 11:5678-5685. (Pubitemid 41170290)
7. Carey LA, Dees EC, Sawyer L, et al: The triple negative paradox: primary tumor chemo-sensitivity of breast cancer subtypes. Clin Cancer Res 2007; 13: 2329-2334. (Pubitemid 46698581)
8. Nielsen TO, Hsu FD, Jensen K, et al: Immu-nohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 2004; 10: 5367-5374. (Pubitemid 39100473)
9. Cheang MC, Voduc D, Bajdik C, et al: Basal-like breast cancer def i ned by f ive biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 2008; 14:1368-1376. (Pubitemid 351413917)
10. Cheang MC, Chia SK, Voduc D, et al: Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst 2009; 101:736-750.
11. Voduc KD, Cheang MC, Tyldesley S, et al: Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 2010; 28: 1684-1691.
12. Ge Y, Sneige N, Eltorky MA, et al: Immuno-histochemical characterization of subtypes of male breast carcinoma. Breast Cancer Res 2009; 11:R28.
13. Goldhirsch A, Wood WC, Coates AS, et al: Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 2011; 22:1736-1747.
14. de Azambuja E, Cardoso F, de Castro G Jr, et al: Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. Br J Cancer 2007; 96:1504-1513. (Pubitemid 46762956)
15. Stuart-Harris R, Caldas C, Pinder SE, Pharoah P: Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients. Breast 2008; 17:323-334.
16. Kornegoor R, Verschuur-Maes AH, Buerger H, et al: Molecular subtyping of male breast cancer by immunohistochemistry. Mod Pathol 2012; 25: 398-404.
17. Giordano SH, Buzdar AU, Hortobagyi GN: Breast cancer in men. Ann Intern Med 2002; 137:678-687. (Pubitemid 35176102)
18. Curigliano G, Colleoni M, Renne G, et al: Recognizing features that are dissimilar in male and female breast cancer: expression of p21Waf1 and p27Kip1 using an immunohis-tochemical assay. Ann Oncol 2002; 13: 895-902. (Pubitemid 34752685)
19. Farhat GN, Cummings SR, Chlebowski RT, et al: Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers. J Natl Cancer Inst 2011; 103:562-570.
20. Callari M, Cappelletti V, De Cecco L, et al: Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer. Breast Cancer Res Treat 2011; 127:601-610.
21. Vetto J, Jun SY, Paduch D, Eppich H, Shih R: Stages at presentation, prognostic factors, and outcome of breast cancer in males. Am J Surg 1999; 177: 379-383. (Pubitemid 29252805)
22. Bloom KJ, Govil H, Gattuso P, Reddy V, Francescatti D: Status of HER-2 in male and female breast carcinoma. Am J Surg 2001; 182: 389-392. (Pubitemid 33079093)
23. Muir D, Kanthan R, Kanthan SC: Male versus female breast cancers. A population-based comparative immunohistochemical analysis. Arch Pathol Lab Med 2003; 127:36-41. (Pubitemid 36236577)
24. Rudlowski C, Friedrichs N, Faridi A, et al: Her-2/neu gene amplification and protein expression in primary male breast cancer. Breast Cancer Res Treat 2004; 84:215-223. (Pubitemid 38445371)
25. Ciocca V, Bombonati A, Gatalica Z, et al: Cytokeratin profiles of male breast cancers. Histopathology 2006; 49:365-370. (Pubitemid 44401543)